Yvonne L. Greenstreet
2021
Compensation breakdown
| Non-Equity Incentive Plan | $429,120 |
|---|---|
| Option Awards | $7,341,000 |
| Salary | $619,100 |
| Other | $186,000 |
| Total | $8,575,220 |
Greenstreet received $7.3M in option awards, accounting for 86% of the total pay in 2021.
Greenstreet also received $429.1K in non-equity incentive plan, $619.1K in salary and $186K in other compensation.
Rankings
In 2021, Yvonne L. Greenstreet's compensation ranked 1,316th out of 12,415 executives tracked by ExecPay. In other words, Greenstreet earned more than 89.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,316 out of 12,415 | 89th |
Division Manufacturing | 468 out of 5,505 | 92nd |
Major group Chemicals And Allied Products | 170 out of 2,375 | 93rd |
Industry group Drugs | 142 out of 2,096 | 93rd |
Industry Pharmaceutical Preparations | 93 out of 1,546 | 94th |
Pay ratio
| Yvonne L. Greenstreet's Pay | $8,575,220 |
|---|---|
| Median Employee's Pay | $231,163 |
| Pay Ratio | 37to 1 |
In 2021, the annual total compensation of Yvonne L. Greenstreet was $8,575,220.
The annual total compensation of the median employee at Alnylam Pharmaceuticals was $231,163.
The ratio of Yvonne L. Greenstreet's pay to the pay of median employee was therefore 37 to one.
Greenstreet's colleagues
We found four more compensation records of executives who worked with Yvonne L. Greenstreet at Alnylam Pharmaceuticals in 2021.
2021
John Maraganore
Alnylam Pharmaceuticals
Chief Executive Officer
2021
Tolga Tanguler
Alnylam Pharmaceuticals
Executive Vice President, Chief Commercial Officer
2021
Akshay Vaishnaw
Alnylam Pharmaceuticals
President, Research and Development
2021
Jeffrey Poulton
Alnylam Pharmaceuticals